Evidence map›Paper›PMID 40468633›Full record

ReviewSmall methods2025

Deep Learning Based Models for CRISPR/Cas Off-Target Prediction.

Mingming Cao, Alexander Brennan, Ciaran M Lee, So-Hyun Park, Gang Bao

Abstract readReview
In one paragraph

Review in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingming CaoDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.
Alexander BrennanSchool of Biochemistry and Cell Biology, University College Cork, Cork, T12 K8AF, Ireland.
Ciaran M LeeSchool of Biochemistry and Cell Biology, University College Cork, Cork, T12 K8AF, Ireland.
So-Hyun ParkDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.
Gang BaoDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.ORCID https://orcid.org/0000-0001-5501-554X

Funding

Precision mapping of regulatory causal variants by expression CROPseqR01HG011459 · NHGRI · GEORGIA INSTITUTE OF TECHNOLOGY · PI BAO, GANG, GIBSON, GREGORY C · 2021 to 2025
$3.5M
Deciphering unintended large gene modifications in gene editing for sickle cell diseaseR01HL169761 · NHLBI · RICE UNIVERSITY · PI Gang Bao · 2023 to 2026
$2.7M
Cancer Prevention and Research Institute of Texas RP210116NHGRI NIH HHS R01 HG011459NHGRI NIH HHS R01HG011459NHLBI NIH HHS R01 HL169761NHLBI NIH HHS R01HL169761
6 · The paper itself

Abstract

CRISPR/Cas genome editing technologies enable effective and controlled genetic modifications; however, off-target effects remain a significant concern, particularly in clinical applications. Experimental and in silico methods are developed to predict potential off-target sites (OTS), including deep learning based methods, which can automatically and comprehensively learn sequence features, offer a promising tool for OTS prediction. Here, this work reviews the existing OTS prediction tools with an emphasis on deep learning methods, characterizes datasets used for deep learning training and testing, and evaluates six deep learning models -CRISPR-Net, CRISPR-IP, R-CRISPR, CRISPR-M, CrisprDNT, and Crispr-SGRU -using six public datasets and validates OTS data from the CRISPRoffT database. Performance of these models is assessed using standardized metrics, such as Precision, Recall, F1 score, MCC, AUROC and PRAUC. This work finds that incorporating validated OTS datasets into model training enhanced overall model performance, and improved robustness of prediction, particularly with highly imbalanced datasets. While no model consistently outperforms other models across all scenarios, CRISPR-Net, R-CRISPR, and Crispr-SGRU show strong overall performance. This analysis demonstrates the importance of integrating high-quality validated OTS data with advanced deep learning architectures to improve CRISPR/Cas off-target site predictions, ensuring safer genome editing applications.

Indexed as

CRISPR-Cas SystemsDeep LearningGene EditingHumansCRISPR/Casdeep learning modelgene editingoff‐target sites

Identifiers

PMID40468633
PMCPMC12286732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.